IQS Tech Transfer SALUT has been accredited as an official agent since April 2025, Consolidating its position as a benchmark in research and technology transfer in advanced and emerging therapies, densazón, nanomedicine, and the development of new drugs. Cuenta con el apoyo de varias plataformas y laboratorios de IQS Including the Cell Culture and Tissue Engineering Laboratories, Bioprocess Engineering Laboratory, Cell Line Characterization Laboratory, Pharmaceutical Characterization Laboratory, Biochemical Analysis Laboratory, Advanced Materials and Nanotechnology Laboratory, Biotherapies Laboratory, as well as the IQS-SCIEX Platform, and IQS-JEOL RMN Platform. The agent carries out R&D activities focused on developing new functional materials for biomedical applications, drug delivery systems, advanced and emerging therapies, nanotechnology and densazón, as well as other technologies aimed at treating a wide range of diseases. Its research team is part of several SGR groups, standing out for its multidisciplinary expertise and strong commitment to applied innovation.
IQS Tech Transfer SALUT research lines focus primarily on the development of new functional materials for biomedical applications and nanomedicine. IQS Tech Transfer SGR includes researchers who are part of several recognized groups: GEMAT (Materials Engineering Group), GEVAB (Vascular Engineering and Applied Biomedicine Group), and GQBB (Biological Chemistry and Biotechnology Group).
Within this framework, the Tecnio agent IQS Tech Transfer SALUT carries out its R&D and technology transfer activities in the following areas, focusing on cell sourcing and advanced therapies:
- Development of biodegradable polymers and creation of biomaterials for scaffolds.
- Biomaterials for cardiovascular pathologies (atherosclerosis, aneurysms).
- Design of drug delivery systems using polymeric nanoparticles and extracellular vesicles.
- Synthesis, characterization, and purification of nanoparticles.
- Functionalization of PLGA nanoparticles.
- Design of non-viral vectors for gene therapy.
- Optimization of nanoformulations with organ-specific targeting.
- Formulation of mRNA vaccines using nanosystems.
- Design of cancer immunotherapies.
- Development of peptides for biomedical applications.
- Generation of modified therapeutic proteins through genetic code expansion and bioorthogonal chemistry.
- Design of targeted drug delivery systems for the brain.
- Development of stimuli-responsive proteins and nanomaterials.
- Creation of hybrid vectors for gene therapy in monogenic diseases.
- Local RNA delivery systems for muscle regeneration.
- Toxicity, biodistribution, and efficacy studies in preclinical mouse models.
- RNA delivery to antigen-presenting cells in vitro and in vivo.
- Investigation of molecular and cellular mechanisms of vascular diseases.
- Production of recombinant proteins, monoclonal antibodies, and vaccine candidates.
- Design of bioreactors and disposable components.
- Development and optimization of bioprocesses.
- Cell culture (hESC, iPSC), microalgae, and plant cells.
- Study of bioadhesive–tissue interactions.
- Nanotechnology for cancer treatment.
- Smart biomaterials for cartilage regeneration.
- Development of injectable and biocompatible materials.
- Gene therapy using nanotechnology.
- Cartilage regeneration and osteoarthritis treatment.
- Research on glycogen accumulation in neurodegenerative diseases.
- Study of energy metabolism in the nervous system.
- Exploration of non-canonical functions of glycogen metabolism.
- Development of therapies for Alzheimer’s and other neurodegenerative diseases.
- Study of amyloid proteins.
This summary highlights the main research areas and objectives of the agent’s researchers, emphasizing their contribution to the field of health and advanced therapies..
The following researchers are part of the agent: Dr. Carles Bofill Bonet, Dr. Salvador Borrós, Dra. Glòria Nieva, Dra. Cristina Fornaguera, Dr. Michael Bruyns-Haylett , Dra. Marta Guerra, Dr. Francesc Guix, Dr. Martí Lecina, Dra. Roberta Lucchi, Dra. Núria Oliva, Dr. Benjamí Oller, Dra. Patricia González, Dra. Cristina Díaz Perlas, Dr. Robert Texidó, Dra. Mercedes Balcells, Dr. Jordi Martorell, Dr. José Javier Molins i Dr. Jordi Duran.
Contact: iqstt_salut@iqs.url.edu
